Niigata Cancer Center

Niigata 951-8566

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, EGFR Exon 20 Mutation, Non Small Cell Lung Cancer

Studies at this site

• A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer — Running, not enrolling
• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] — Running, not enrolling